Cardiopulmonary Stress Testing Systems Market By Product Type (Cardiopulmonary Exercise Testing Systems, Stress ECG, Pulse Oximeters, Stress Blood Pressure Monitors, Single-Photon Emission Computed Tomography), By End-User Segment (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic and Cardiology Centers) - Growth, Future Prospects, and Competitive Analysis, 2019 - 2027

Cardiopulmonary stress testing systems market to exhibit dynamic growth during the forecast period.

The global cardiopulmonary stress testing systems market is growing efficiently, expected to grow at a CAGR of 4.8%. Globally, growing diagnostic procedures for cardiovascular-related disorders such as heart valve imbalance and arrhythmia will drive market growth. Increasing awareness about new lifestyle diseases along with heart and lung disorders are factors driving the overall growth of the cardiopulmonary stress testing systems market globally. Other major factors include development in the portable device industry, the invention of high-sensitivity ECG devices, growth in the cardiovascular centers for enhanced diagnostics, and new technology expansion in emerging nations at low cost. 

Market Synopsis

Cardiopulmonary exercise testing systems segment expected to register higher growth by the end of 2027.

Advancements in cardiac diagnostic testing, along with the development in the field of echocardiograph testing devices and exercise tolerance testing devices, will enhance the overall demand. Cardiopulmonary exercise (CPX) testing devices will show promising growth on a global scale. The increasing trend for wireless devices is expanding significantly and has the capability to detect specific conditions related to the heart or lungs along with smart features. For e.g., K5 wearable metabolic systems (COSMED), Orbit-K Blood Pressure Cuff, Oxycon mobile cardiopulmonary stress testing, and others. The global manufacturers are focusing on new product launches and further R&D for the commercialization of these testing systems to meet the active demand in the near future.

Diagnostic and cardiology centers to witness a significant CAGR.

The higher average selling price of stress testing systems, increasing adoption of new products along with its services provided at cardiac centers, and increasing preference for portable cardiopulmonary testing systems on a global scale are prominent factors expected for the growth of the market. Hospitals generated the maximum revenue share in 2018 due to the large patient pool and increasing preference of hospital physicians as well as individuals for the early diagnosis of cardiovascular-related diseases. Higher demand in developing nations, product expansion, and awareness for enhanced outcomes will drive market growth in the end-user segment globally. 

Increasing population, new FDA approval, and the presence of top manufacturers hold North America in a dominant position.

In 2018, the U.S. generated the maximum revenue share in the cardiopulmonary stress testing systems market due to an increase in the prevalence of lifestyle disorders, rising hospital admissions, and the launch of new stress testing systems. Growing adoption of early cardiopulmonary diagnosis practices, increased patient pool in the U.S. and Canada, and increasing adoption and penetration of advanced testing systems at public health centers/institutes that aid nurses and hospital physicians for patient health monitoring in real-time are major factors driving the growth in North America. To upsurge their economic edge globally, top manufacturers have concentrated on the procedure of partnerships & collaborations, adoption of new techniques, and launch of medical technology products. However, the higher expense of software-based arrangements, less popularity among physicians, complexity in R&D, and constrained returns may hinder the market growth during the forecast period. 

Increased research and development with strong product pipelines in the developed regions

Major players in the cardiopulmonary stress testing systems market are GE Healthcare, Thermo Fisher Scientific Ltd., Cardinal Health, Cosmed Medical, Spacelabs Healthcare, Koninklijke Philips N.V., NIHON KOHDEN CORPORATION, Vyaire Medical Inc., Hill-Rom Holdings Inc., Masimo, MGC Diagnostics Corporation, Schiller AG, MGC Diagnostics Corporation and others. Major top organizations are emerging with smart technologies with integrated software systems. Partnerships acquisitions and improved R&D on medical equipment will improvise the development of the cardiopulmonary stress testing systems market in developing nations in the near future. 

Historical & Forecast Period

This study report represents an analysis of each segment from 2017 to 2027, considering 2018to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2019 to 2027. 

Report Scope by Segments

Market Segmentation: Global Cardiopulmonary Stress Testing Systems Market 


Research Period  2017-2027

The base Year 2018

Forecast Period  2019-2027

Historical Year  2017

Unit  USD Million

Segmentation Product Type (2017–2027; US$ Mn)

  • Cardiopulmonary Exercise Testing (CPET) Systems
  • Stress ECG
  • Pulse Oximeters
  • Stress Blood Pressure Monitors
  • Single-Photon Emission Computed Tomography (SPECT)

End-User Segment (2017–2027; US$ Mn)

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Diagnostic and Cardiology Centers

Geography Segment (2017–2027; US$ Mn)

  • North America (U.S., Canada)
  • Europe (U.K., Germany, Rest of Europe)
  • Asia Pacific (Japan, China, Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • Middle East & Africa (GCC, Rest of Middle East & Africa)

The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints, and opportunities that give a better market understanding of the overall cardiopulmonary stress testing systems market. Additionally, the global report also comprises a graphical representation of the competitive landscape based on their market initiatives and strategies, product portfolio, and business strengths.

Key questions answered in this report. 

  • What are the current market trends and dynamics in the cardiopulmonary stress testing systems market and valuable opportunities for emerging players?
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which product type segment holds a larger market share and why?
  • Are low and middle-income economies investing in the cardiopulmonary stress testing systems market?
  • What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Frequently Asked Question:

The market for Cardiopulmonary Stress Testing Systems Market is expected to reach USD$ XX Bn in 2027.

The Cardiopulmonary Stress Testing Systems Market is expected to see significant CAGR growth over the coming years, at 4.8%.

The report is forecasted From 2019-2027.

The base year of this report is 2018.

GE Healthcare, Thermo Fisher Scientific Ltd., Cardinal Health, Cosmed Medical, Spacelabs Healthcare, Koninklijke Philips N.V., NIHON KOHDEN CORPORATION, Vyaire Medical Inc. are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Jul 2019
Category:  Medical Devices
Report ID:   59808
Report Format:   PDF
Pages:   120
Rating:    4.2 (58)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support